Dashboard
1
With a fall in PBT of -256.88%, the company declared Very Negative results in Mar 25
- The company has declared negative results in Jan 70 after 2 consecutive negative quarters
- NET SALES(Q) At VND 63,555.05 MM has Fallen at -17.95%
- PRE-TAX PROFIT(Q) At VND -2,719.45 MM has Fallen at -238.56%
- NET PROFIT(Q) At VND -3,070.83 MM has Fallen at -365.29%
2
Risky -
3
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.0%
0%
20.0%
6 Months
-37.93%
0%
-37.93%
1 Year
-53.85%
0%
-53.85%
2 Years
-51.35%
0%
-51.35%
3 Years
-84.81%
0%
-84.81%
4 Years
-84.93%
0%
-84.93%
5 Years
-80.61%
0%
-80.61%
American Vietnamese Biotech, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.99%
EBIT Growth (5y)
-182.66%
EBIT to Interest (avg)
2.61
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.15
Tax Ratio
58.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.68%
ROE (avg)
4.40%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
9.58
EV to EBITDA
3.44
EV to Capital Employed
0.08
EV to Sales
0.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.86%
ROE (Latest)
-0.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
39,522.10
12,690.80
211.42%
Operating Profit (PBDIT) excl Other Income
2,063.60
8,686.30
-76.24%
Interest
4,983.00
4,480.40
11.22%
Exceptional Items
197.10
0.00
Consolidate Net Profit
-3,293.60
-10,861.40
69.68%
Operating Profit Margin (Excl OI)
52.20%
8.30%
4.39%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 211.42% vs -66.86% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 69.68% vs 71.14% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
154,066.60
310,354.60
-50.36%
Operating Profit (PBDIT) excl Other Income
5,327.00
19,689.90
-72.95%
Interest
18,655.30
19,650.50
-5.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-54,503.70
-13,065.20
-317.17%
Operating Profit Margin (Excl OI)
-179.00%
-13.90%
-16.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -50.36% vs 57.88% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -317.17% vs -221.74% in Dec 2024
About American Vietnamese Biotech, Inc. 
American Vietnamese Biotech, Inc.
Medical Specialties
American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.
Company Coordinates 
Company Details
So 1251 QL 14, thi xa Dong Xoai , HO CHI MINH None : None
Registrar Details






